1 unchanged sentence
Market Information
−Removed: Our common stock, par value $0.001 per share, has been publicly traded on the Nasdaq Global Market under the symbol “LPTX” since January 24, 2017.
+Added: Our common stock, par value $0.001 per share, is publicly traded on the Nasdaq Capital Market under the symbol “LPTX” since January 24, 2017.
Prior to that time, there was no market for our common stock.
9 unchanged sentences
Also included is the consideration, if any, received by us for any such shares, options and warrants and information relating to the section of the Securities Act, or rule of the SEC, under which exemption from registration was claimed.
−Removed: January 2020 Private Placement
−Removed: On January 3, 2020, we entered into a Securities Purchase Agreement with investors, providing for a private placement transaction exempt from the Securities Act, pursuant to which we issued and sold 1,421,801 shares of our Series A Preferred Stock, at a purchase price of $10.54 per share, 1,137,442 shares of our Series B Preferred Stock at a purchase price of $10.55 per share, and one (1) share of our Special Voting Stock entitling the purchaser of Series A Preferred Stock to elect one member to our board of directors (the “January 2020 Private Placement”).
−Removed: On March 5, 2020, our stockholders approved the conversion of the Series A Preferred Stock into a pre-funded warrant to purchase 14,413,902 shares of common stock at an exercise price of $0.001 (the “March 2020 Pre-funded Warrants”) and the conversion of the Series B Preferred Stock into 11,531,133 shares of common stock.
−Removed: Each investor also received a warrant to purchase an equal number of shares of common stock at an exercise price of $2.11 per share (the “Coverage Warrants”).
−Removed: The March 2020 Pre-funded Warrants and the Coverage Warrants expire on March 5, 2027 and qualify for equity classification.
−Removed: The securities issued and sold in connection with the January 2020 Private Placement were offered pursuant to Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D as promulgated by the SEC under the Securities Act.
−Removed: Each purchaser was either (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a “qualified institutional buyer” as defined in Rule 144A(a) under the Securities Act and acquired the securities for investment purposes only and not with a view to, or for sale in connection with, any distribution thereof.
−Removed: The securities were not issued through any general solicitation or advertisement.
Acquisition of Flame Biosciences
1 unchanged sentence
Pursuant to the merger, we issued an aggregate of approximately 1,979,437 shares of Common Stock, and approximately 136,833 shares of Series X Non-Voting Convertible Preferred Stock to the shareholders of Flame.
−Removed: Subject to and upon the requisite approval of our stockholders, each share of Series X Preferred Stock shall convert into 1,000 shares of Common Stock.
+Added: On June 16, 2023, we obtained Stockholder Approval to convert each share of Series X Preferred Stock into 100 shares of our common stock.
The securities issued and sold in connection with the merger are exempt from registration under the Securities Act in reliance on Section 4(a)(2) thereof and Regulation D promulgated thereunder.
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.